Video Experimental Relacionado
Updated: Sep 8, 2025
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.0K
El continuo de la dermatitis atópica: un paradigma actualizado para un trastorno común y una nueva opción de
Journal of drugs in dermatology : JDD
|September 5, 2025
Resumen
El hidrogel tópico de zabalafina se dirige eficazmente a los cuatro factores clave de la dermatitis atópica (DA): inflamación, infección, prurito y xerosis. Este enfoque multidireccional es prometedor para el tratamiento de esta afección crónica de la piel.
Área de la Ciencia:
- Dermatología
- Inmunología
- Microbiología
Sus antecedentes:
- La dermatitis atópica (DA) es una enfermedad inflamatoria crónica de la piel con desencadenantes complejos.
- Las terapias actuales no abordan completamente todas las manifestaciones de la enfermedad de Alzheimer, lo que indica la necesidad de tratamientos multidireccionales.
Objetivo del estudio:
- Revisar los desencadenantes y las presentaciones patológicas de la EA.
- Evaluar la eficacia del hidrogel tópico de zabalafina en un ensayo clínico de fase 2a.
Principales métodos:
- El panel de expertos realizó una revisión estructurada de la literatura.
- Declaraciones de consenso desarrolladas sobre los desencadenantes y el continuo de AD.
- Ensayos clínicos de fase 2a de hidrogel tópico de zabalafina en pacientes con EA de leve a moderada.
Principales resultados:
- Se identificaron cuatro presentaciones patológicas interdependientes de la EA: inflamación, colonización / disbiosis / infección, xerosis y prurito.
- El hidrogel tópico de zabalafina redujo la inflamación, la colonización/infección por Staphylococcus aureus, la disbiosis, el prurito y la xerosis.
- El hidrogel de Zabalafin demostró efectos adversos mínimos.
Conclusiones:
- La dermatitis atópica requiere estrategias terapéuticas multi-objetivo que aborden su continuo.
- El hidrogel de Zabalafin muestra potencial para el control sostenido de la EA al dirigirse a procesos patológicos interconectados.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446
01:20Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:30Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
01:19Antiasthma Drugs: Leukotriene Modifiers
453
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
453